NasdaqGM - Delayed Quote USD

SANUWAVE Health, Inc. (SNWV)

5.15 -0.12 (-2.28%)

At close: October 30 at 4:00:00 PM EDT

Trade SNWV on Coinbase

Chart Range Bar

Advanced Chart

AlphaSpace Chart

Loading chart for SNWV

Previous Close 5.27
Open 4.96
Bid 4.30 x 200
Ask 7.57 x 200
Day's Range 4.96 - 5.23
52 Week Range 3.92 - 36.20
Volume 11,908
Avg. Volume 61,362
Market Cap (intraday) 44.302M
Beta (5Y Monthly) 1.42
PE Ratio (TTM) 21.46
EPS (TTM) 0.24
Earnings Date (est.) Nov 6, 2026
Forward Dividend & Yield -- (0.00%)
Ex-Dividend Date --
1y Target Est --

SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds. The company was founded in 2004 and is headquartered in Eden Prairie, Minnesota.

sanuwave.com

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SNWV

82.74%

S&P 500 (^GSPC)

10.73%

1-Year Return

SNWV

81.62%

S&P 500 (^GSPC)

11.11%

3-Year Return

SNWV

48.50%

S&P 500 (^GSPC)

81.91%

5-Year Return

SNWV

48.50%

S&P 500 (^GSPC)

64.59%

Earnings Per Share (GAAP)

Revenue vs. Earnings

yearly Annual

quarterly Quarterly

yearly Annual

quarterly Quarterly

Q4 FY25

Revenue 13.39M

Earnings 7.69M

Profit Margin 57.43%

FY25

-5M

10M

0.0%

20.0%

40.0%

60.0%

80.0%

Valuation Measures

  
  
 Annual 

Market Cap
Enterprise Value
Trailing P/E
Forward P/E
PEG Ratio (current)
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

Profit Margin

34.66%
Return on Assets (ttm)

5.51%
Return on Equity (ttm)

--
Revenue (ttm)

44.02M
Net Income Avi to Common (ttm)

15.26M
Diluted EPS (ttm)

0.24

Balance Sheet and Cash Flow

Total Cash (mrq)

9.38M
Total Debt/Equity (mrq)

742.95%
Levered Free Cash Flow (ttm)

-2.83M

CDIX Cardiff Lexington Corporation

0.0130 +23.81%

AMNC Amincor, Inc.

0.0200 0.00%

BLTH American Battery Materials, Inc.

2.0500 0.00%

PRSI Portsmouth Square, Inc.

5.60 -0.18%

POFCY Petrofac Limited

0.0001 0.00%

U.S. markets closed

SANUWAVE Health, Inc. (SNWV)

Trading disclosure

-1.34%

9.34%

-68.54%

-82.74%

-81.62%

-48.50%

-48.50%

SANUWAVE Health, Inc. Overview Medical Devices / Healthcare

Full Time Employees

Fiscal Year Ends

Sector

Industry

Recent News

Performance Overview

YTD Return

1-Year Return

3-Year Return

5-Year Return

Earnings Trends

Earnings Per Share (GAAP)

Revenue vs. Earnings

Statistics

Valuation Measures

Financial Highlights

Profitability and Income Statement

Balance Sheet and Cash Flow

Company Insights

Research Reports

People Also Watch